April 12, 2025 04:17 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
15 flights diverted, many delayed as dust storm hits Delhi, Haryana | AIADMK, BJP join hands again to contest Tamil Nadu elections under Edappadi K Palaniswami | PM Modi inaugurates Rs. 3,880-cr projects in Varanasi on 50th visit to his Lok Sabha constituency | Bengal job losers camp outside SSC office in Kolkata, demand mirror copies of genuine candidate list | Mumbai terror attack accused Tahawwur Rana sent to 18-day NIA custody | Donald Trump's latest tariff hike on Beijing brings additional rate on some Chinese goods to 145 pct: White House | Pakistan distances itself from 26/11 terror accused Tahawwur Rana, says he is 'Canadian national' | Tahawwur Rana’s extradition proof of Modi govt's diplomatic strength: Amit Shah | Adult unmarried parents can live together without marriage: Allahabad High Court | Bengal job losers hold massive rally in Kolkata protesting over police assault
Glenmark launches Tavulus for COPD treatment in Spain

Glenmark launches Tavulus for COPD treatment in Spain

Oct 11, 2021, at 07:18 pm

Mumbai/UNI: Pharma major Glenmark Pharma Monday announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).

Latest Headlines
Glenmark launches Tavulus for COPD treatment in Spain Mon, Oct 11 2021
Close menu